5-Hydroxytryptamine (5-HT) concentrations in the hippocampus, the hypothalamus and the medulla oblongata related to cisplatin-induced pica of rats

Research Communications in Molecular Pathology and Pharmacology

Volumn 113-114, Issue , 2003, Pages 97-113

  Liu, Yanxia ^a   Hamaue, Naoya ^a   Endo, Toru ^a   Hirafuji, Masahiko ^a   Minami, Masaru ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

5 Hydroxytryptamine (5 HT); Brain regions; Brainstem; Cisplatin; Cisplatin induced emesis; Cytotoxic drugs; Dopamine; Emesis; Ferrets; Hippocampus; Hypothalamus; Kaolin ingestion (pica); Medulla oblongata; Norepinephrine (NE)

Indexed keywords

CISPLATIN; DOPAMINE; KAOLIN; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CONTROLLED STUDY; FERRET; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MEDULLA OBLONGATA; NONHUMAN; PICA; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SINGLE DRUG DOSE; VOMITING;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN; CISPLATIN; DOPAMINE; HYDROXYINDOLEACETIC ACID; KAOLIN; MALE; NOREPINEPHRINE; PICA; RATS; RATS, WISTAR; SEROTONIN; SYMPATHOMIMETICS; VOMITING;

EID: 13144258739     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Alfieri, A.B. and Cubeddu, L.X. (1995). Treatment with para-chlorophenylalanine antagonizes the emetic response and the serotonin-releasing actions of cisplatin in cancer patients. Br. J. Cancer. 71: 629-632.
2. Andrews, P.L.R., Rapeport, W.G. and Sanger, G.J. (1988). Neuropharmacology of emesis induced by anti-cancer therapy. Trends. Pharmacol. Sci. 9: 334-341.
3. Andrews, P.L.R. (1992). Physiology of nausea and vomiting. Br. J. Anaesth. 69 (Suppl 1): 2S-19S.
4. Andrews, P.L.R. and Davis, C.J. (1995). The physiology of emesis induced by anticancer therapy. In: Serotonin and the Scientific Basis of Antiemetic Therapy. Edited by Reynolds, D.J.M., Andrews, P.L.R. and Davis, C.J. Oxford Clinical Communication, Oxford, UK. pp. 25-48.
5. Borison, H.L. and Wang, S.C. (1953). Physiology and pharmacology of vomiting. Pharmacol. Rev. 5: 193-230.
6. Borison, H.L., Borison, R. and McCarthy, L.E. (1984). Role of the area postrema in vomiting and related functions. Fed. Proc. 43: 2955-2958.
7. Carpenter, D.O., Briggs, D.B. and Strominger, N. (1983). Responses of neurons of canine area postrema to neurotransmitters and peptides. Cell. Mol. Neurobiol. 3: 113-126.
8. Castejon, A.M., Paez, X., Hernandez, L. and Cubeddu, L.X. (1999). Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron. J. Pharmacol. Exp. Ther. 291: 960-966.
9. Costall, B., Domeney, A.M., Naylor, R.J. and Tattersall, F.D. (1986). 5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis. Neuropharmacology 25: 959-961.
10. Cubeddu, L.X., Hoffmann, I.S., Fuenmayor, N.T. and Finn, A.L. (1990). Efficacy of ondansetron (GR38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N. Engl. J. Med. 322: 810-816.
11. 1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2. Eur. J. Pharmacol. 430: 49-58.
12. Endo, T., Minami, M., Monma, Y., Saito, H. and Takeuchi, M. (1990). Emesis-related biochemical and histopathological changes induced by cisplatin in the ferret. J. Toxicol. Sci. 15:235-244.
13. 3 antagonist) inhibited the increase of serotonin concentration induced by cytotoxic drugs in the area postrema of ferrets. Biogenic Amines 9: 163-175.
14. Endo, T., Nemoto, M., Ogawa, T., Tamakai, H., Hamaue, N., Hirafuji, M., Takeda, Y., Hasegawa, M., Fugii, Y. and Minami, M. (2000). Pharmacological aspects of ipecac syrup (TJN-119)-induced emesis in ferrets. Res. Commun. Mol. Pathol. Pharmacol. 108: 187-200.
15. Frazer, A. and Hensler, J.G. (1999). Serotonin. In: Basic Neurochemistry. Edited by Siegel, G.J., Agranoff, B.W., Albers, R.W., Fisher, S.K. and Uhler, M.D. Lippincott Williams and Wilkins, Philadelphia, pp. 263-292.
16. 3H]dopa in various regions of the brain. J. Neurochem. 13: 655-669.
17. Hasler, W.L. Serotonin receptor physiology: relation to emesis. (1999). Dig. Dis. Sci. 44 (Suppl 8): 108-113.
18. Higgins, G.A., Kilpatrick, G.J., Bunce, K.T., Jones, B.J. and Tyers, M.B. (1989). 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br. J. Pharmacol. 97: 247-255.
19. Kudo, C., Minami, M., Hirafuji, M., Endo, T., Hamaue, N., Akita, K., Murakami, T. and Kawaguchi, H. (2001). The effects of nabumetone, a cyclooxygenase-2 inhibitor, on cisplatin-induced 5-hydroxytryptamine release from the isolated rat ileum. Res. Commun. Mol. Pathol. Pharmacol. 110: 117-132.
20. Leslie, R.A. (1985). Neuroactive substances in the dorsal vagal complex of the medulla oblongata: nucleus of the tractus solitarius, area postrema and dorsal motor nucleus of the vagus. Neurochem. Int. 7: 191-211.
21. Leslie, R.A., Reynolds, T.M. and Lawes, I.N.C. (1992). Central connections of the nuclei of the vagus nerve. In: Neuroanatomy and Physiology of Abdominal Vagal Afferents. Edited by Ritter, S., Ritter, R.C. and Barnes, C.D. CRC Press, Boca Raton, FL. pp. 81-98.
22. Lowry, O.H., Rosenbrough, N.J., Farr, A.L. and Randall, R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275.
23. Lucot, J.B. and Crampton, G.H. (1989). 8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine. Pharmacol. Biochem. Behav. 33: 627-631.
24. Milano, S., Simon, C. and Grelot, L. (1991). In vitro release and tissue levels of ileal serotonin after cisplatin-induced emesis in the cat. Clin. Auton. Res. 1: 275-280.
25. Miller, A.D. and Wilson, V.J. (1983). 'Vomiting center' reanalyzed: an electrical stimulation study. Brain. Res. 270: 154-158.
26. Miller, A.D., Nonaka, S. and Jakus, J. (1994). Brain areas essential or non-essential for emesis. Brain. Res. 647: 255-264.
27. Miller, A.D. and Ruggiero, D. A. (1994). Emetic reflex arc revealed by expression of the immediate-early gene c-fos in the cat. J. Neurosci. 14: 871-888.
28. Minami, M., Sano, M., Togashi, H., Sakurai, H. and Saito, H. (1988). Stroke-related plasma noradrenaline, angiotensin II, and serotonin concentrations in stroke-prone spontaneously hypertensive rats. In: Progress in Hypertension, vol. 1. Edited by Saitom, H., Parvez, H., Parvez, S. and Nagatsu, T. VSP, Utrecht, The Netherlands, pp. 89-114.
29. Minami, M., Endo, T., Nemoto, M., Hamaue, N., Hirafuji, M., Monma, Y., Yajima, T., Yoshioka, M. and Saito, H. (1995). How do toxic emetic stimuli cause 5-HT release in the gut and brain? In: Serotonin and Scientific Basis of Anti-emetic Therapy. Edited by Reynolds, D.J.M., Andrews, P.L.R. and Davis, C. Oxford Clinical Communications, Oxford, UK. pp. 68-76.
30. Minami, M., Ogawa, T., Endo, T., Hamaue, N., Hirafuji, M., Yoshioka, M., Blower, P.R. and Andrews, P.L.R. (1997). Cyclophosphamide increases 5-hydroxytryptamine release from the isolated ileum of the rats. Res. Commun. Mol. Pathol. Pharmacol. 97: 13-24.
31. Miner, W.D. and Sanger, G.J. (1986). Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br. J. Pharmacol. 88: 497-499.
32. Mitchell, D., Wells, C., Hoch, N., Lind, K., Woods, S.C. and Mitchell, L.K. (1976). Poison induced pica in rats. Physiol. Behav. 17: 691-697.
33. Mitchell, D., Krusemark, M.L. and Hafner, D. (1977). Pica: a species relevant behavioral assay of motion sickness in the rat. Physiol. Behav. 18: 125-130.
34. Mitchelson, F. (1992). Pharmacological agents affecting emesis: a review (Part I). Drugs. 43:295-315.
35. Morimoto, A., Nakamori, T., Ono, T., Watanabe, T., Sakai, Y. and Murakami, N. (1986). Changes in [14C]deoxyglucose incorporation into rat brain regions during heat-seeking behavior in the cold environment. Physiol. Behav. 38: 275-282.
36. Morita, M., Takeda, N., Kubo, T., Yamatodani, A., Wada, H. and Matsunaga, T. (1988). Effects of anti-motion sickness drugs on motion sickness in rats. ORL. J. Otorhinolaryngol. Relat. Spec. 50: 330-333.
37. Murakawa, M., Adachi, T., Nakao, S., Seo, N., Shingu, K. and Mori, K. (1994). Activation of the cortical and medullary dopaminergic systems by nitrous oxide in rats: a possible neurochemical basis for psychotropic effects and postanesthetic nausea and vomiting. Anesth Analg. 78:376-381.
38. 3 receptor binding sites in human dorsal vagal complex. Eur. J. Pharmacol. 174: 127-130.
39. Rudd, J.A., Yamamoto, K., Yamatodani, A. and Takeda, N. (2002). Differential action of ondansetron and dexamethasone to modify cisplatin-induced acute and delayed kaolin consumption ("pica") in rats. Eur. J. Pharmacol. 454: 47-52.
40. Shintani, F., Kanba, S., Nakaki, T., Nibuya, M., Kinoshita, N., Suzuki, E., Yagi, G., Kato, R. and Asai, M. (1993). Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J. Neurosci. 13: 3574-3581.
41. Takeda, N., Hasegawa, S., Morita, M. and Matsunaga, T. (1993). Pica in rats is analogous to emesis: an animal model in emesis research. Pharmacol. Biochem. Behav. 45: 817-821.
42. Takeda, N., Morita, M., Horii, A., Nishiike, S., Kitahara, T. and Uno, A. (2001). Neural mechanisms of motion sickness. J. Med. Invest. 48: 44-59.
43. Thumas, L.J. (1891). Ueber das brechcentrum und uber die Wirkung eineger pharmakologischer Mittel auf dasselbe. Virchows Arch. Pathol. Anat. 123: 44-69.
44. Tsukuda, M. (2002). Prevention and treatment for adverse events induced by chemotherapy. Jpn. J. Cancer Chemother. 29: 1284-1291.
45. Van Sickle, M.D., Oland, L.D., Ho, W., Hillard, C.J., Mackie, K., Davison, J.S. and Sharkey, K.A. (2001). Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterology 121: 767-774.
46. 3 receptors in the mouse CNS. Eur. J. Pharmacol. 151: 351-352.
47. Wallenstein, S., Zucker, C.L. and Fleiss, J.L. (1980). Some statistical methods useful in circulation research. Circ. Res. 47: 1-9.
48. 1A agonists in the pigeon. Pharmacol. Biochem. Behav. 49: 385-391.
49. Yoshikawa, T. and Yoshida, N. (2002). Effect of 6-hydroxydopamine treatment in the area postrema on morphine-induced emesis in ferrets. Jpn. J. Pharmacol. 89: 422-425.